Pluri Inc Sustainability Reports
Pluri Inc. develops and commercializes cell-based therapeutics and technologies for regenerative medicine and biotechnology applications as a publicly traded company on the Nasdaq Stock Market.
Sector: Health Care
Country: Israel
Exchange: Nasdaq Stock Market
ISIN: US72942G2030
3 reports from 2022 to 2023
Company Profile
Pluri Inc
Pluri Inc. develops and commercializes cell-based therapeutics and technologies for regenerative medicine and biotechnology applications as a publicly traded company on the Nasdaq Stock Market.
Reports